Curiel DT - Search Results

1

Oncolytic virotherapy of meningiomas in vitro with replication-competent adenovirus.

Grill J, Lamfers ML, van Beusechem VW, van der Valk P, Huisman A, Sminia P, Alemany R, Curiel DT, Vandertop WP, Gerritsen WR, Dirven CM. Grill J, et al. Among authors: curiel dt. Neurosurgery. 2005;56(1):146-53; discussion 153-4. doi: 10.1227/01.neu.0000146207.55774.69. Neurosurgery. 2005. PMID: 15617597

2

trans E1 component requirements for maximal replication of E1-defective recombinant adenovirus.

Goldsmith KT, Dion LD, Curiel DT, Garver RI Jr. Goldsmith KT, et al. Among authors: curiel dt. Virology. 1998 Sep 1;248(2):406-19. doi: 10.1006/viro.1998.9293. Virology. 1998. PMID: 9721248 Free article.

3

Interleukin-6 modulated conditionally replicative adenovirus as an antitumor/cytotoxic agent for cancer therapy.

Rancourt C, Piché A, Gomez-Navarro J, Wang M, Alvarez RD, Siegal GP, Fuller GM, Jones SA, Curiel DT. Rancourt C, et al. Among authors: curiel dt. Clin Cancer Res. 1999 Jan;5(1):43-50. Clin Cancer Res. 1999. PMID: 9918201

4

Maturation of dendritic cells accompanies high-efficiency gene transfer by a CD40-targeted adenoviral vector.

Tillman BW, de Gruijl TD, Luykx-de Bakker SA, Scheper RJ, Pinedo HM, Curiel TJ, Gerritsen WR, Curiel DT. Tillman BW, et al. Among authors: curiel tj, curiel dt. J Immunol. 1999 Jun 1;162(11):6378-83. J Immunol. 1999. PMID: 10352250

5

Tumor-specific gene transfer via an adenoviral vector targeted to the pan-carcinoma antigen EpCAM.

Haisma HJ, Pinedo HM, Rijswijk A, der Meulen-Muileman I, Sosnowski BA, Ying W, Beusechem VW, Tillman BW, Gerritsen WR, Curiel DT. Haisma HJ, et al. Among authors: curiel dt. Gene Ther. 1999 Aug;6(8):1469-74. doi: 10.1038/sj.gt.3300969. Gene Ther. 1999. PMID: 10467371

6

Gene therapy for gliomas: molecular targets, adenoviral vectors, and oncolytic adenoviruses.

Alemany R, Gomez-Manzano C, Balagué C, Yung WK, Curiel DT, Kyritsis AP, Fueyo J. Alemany R, et al. Among authors: curiel dt. Exp Cell Res. 1999 Oct 10;252(1):1-12. doi: 10.1006/excr.1999.4623. Exp Cell Res. 1999. PMID: 10502394 Review.

7

Targeting of adenoviral vectors through a bispecific single-chain antibody.

Haisma HJ, Grill J, Curiel DT, Hoogeland S, van Beusechem VW, Pinedo HM, Gerritsen WR. Haisma HJ, et al. Among authors: curiel dt. Cancer Gene Ther. 2000 Jun;7(6):901-4. doi: 10.1038/sj.cgt.7700198. Cancer Gene Ther. 2000. PMID: 10880021

8

Replicative adenoviruses for cancer therapy.

Alemany R, Balagué C, Curiel DT. Alemany R, et al. Among authors: curiel dt. Nat Biotechnol. 2000 Jul;18(7):723-7. doi: 10.1038/77283. Nat Biotechnol. 2000. PMID: 10888838 Review.

9

Progress in cancer gene therapy.

Curiel DT, Gerritsen WR, Krul MR. Curiel DT, et al. Cancer Gene Ther. 2000 Aug;7(8):1197-9. doi: 10.1038/sj.cgt.7700222. Cancer Gene Ther. 2000. PMID: 10975681

10

Blood clearance rates of adenovirus type 5 in mice.

Alemany R, Suzuki K, Curiel DT. Alemany R, et al. Among authors: curiel dt. J Gen Virol. 2000 Nov;81(Pt 11):2605-2609. doi: 10.1099/0022-1317-81-11-2605. J Gen Virol. 2000. PMID: 11038370

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

685 results

Search Page

Filters